World Well being Group. Coronavirus illness (COVID-19) outbreak scenario. 2022. https://covid19.who.int/.
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A speedy recommendation guideline for the prognosis and therapy of 2019 novel coronavirus (2019-nCoV) contaminated pneumonia (customary model). Mil Med Res. 2020;7(1):4.
Wang YX, Zhang Y, Chen JB, Wang MJ, Zhang T, Luo WX, et al. Detection of SARS-CoV-2 and its mutated variants by way of CRISPR-Cas13-based transcription amplification. Anal Chem. 2021;93(7):3393–402.
Liu JJ, Liu Y, Xia HJ, Zou J, Weaver SC, Swanson KA, et al. BNT162b2-elicited neutralization of B.1.617 and different SARS-CoV-2 variants. Nature. 2021;596(7871):273–5.
Wang PF, Nair MS, Liu LH, Iketani S, Luo Y, Guo YC, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021;593(7857):130–5.
Collier DA, De Marco A, Ferreira I, Meng B, Datir RP, Partitions AC, et al. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021;593(7857):136–41.
Wang ZJ, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth in opposition to SARS-CoV-2 one 12 months after An infection. Nature. 2021;595(7867):426–31.
Chen R, Ren CP, Liu M, Ge XP, Qu MS, Zhou XB, et al. Early detection of SARS-CoV-2 seroconversion in people with aggregation-induced near-infrared emission nanoparticle-labeled lateral movement immunoassay. ACS Nano. 2021;15(5):8996–9004.
Wang CW, Yang XS, Gu B, Liu HF, Zhou ZH, Shi LL, et al. Delicate and simultaneous detection of SARS-CoV-2-specific IgM/IgG utilizing lateral movement immunoassay based mostly on dual-mode quantum dot nanobeads. Anal Chem. 2020;92(23):15542–9.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, et al. A serological assay to detect SARS-CoV-2 seroconversion in people. Nat Med. 2020;26(7):1033–6.
Beavis KG, Matushek SM, Abeleda APF, Bethel C, Hunt C, Gillen S, et al. Analysis of the EUROIMMUN anti-SARS-CoV-2 ELISA assay for detection of IgA and IgG antibodies. J Clin Virol. 2020;129: 104468.
Soleimani R, Khourssaji M, Gruson D, Rodriguez-Villalobos H, Berghmans M, Belkhir L, et al. Scientific usefulness of totally automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 sufferers. J Med Virol. 2021;93(3):1465–77.
Shao LJ, Shen LH, Wang HB, Xu XP, Lu XD, Zhu YX, et al. Serological chemiluminescence immunoassay for the prognosis of SARS-CoV-2 an infection. J Clin Lab Anal. 2020;34(10): e23466.
Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, et al. Precision and accuracy of a process for detecting current human immunodeficiency virus infections by calculating the antibody avidity index by an automatic immunoassay-based technique. J Clin Microbiol. 2002;40(11):4015–20.
Nguyen THT, Clapham HE, Phung KL, Nguyen TK, DInh TT, Nguyen THQ, et al. Strategies to discriminate main from secondary dengue throughout acute symptomatic an infection. BMC Infect Dis. 2018;18(1):375.
Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, et al. Asymptomatic service state, acute respiratory illness, and pneumonia as a result of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Information and myths. J Microbiol Immunol Infect. 2020;53(3):404–12.
Bauer G. The variability of the serological response to SARS-Corona virus-2: potential decision of ambiguity by willpower of avidity (useful affinity). J Med Virol. 2021;93(1):311–22.
Abdulhalim I. Coupling configurations between prolonged floor electromagnetic waves and localized floor plasmons for ultrahigh subject enhancement. Nanophotonics. 2018;7(12):1891–916.
Abdulhalim I. Plasmonic sensing utilizing metallic nano-sculptured skinny movies. Small. 2014;10(17):3499–514.
Srivastava SK, Grüner C, Hirsch D, Rauschenbach B, Abdulhalim I. Enhanced intrinsic fluorescence from carboxidized nano-sculptured skinny movies of silver and their utility for label free twin detection of glycated hemoglobin. Decide Specific. 2017;25(5):4761–72.
Li A, Isaacs S, Abdulhalim I, Li SZ. Ultrahigh enhancement of electromagnetic fields by thrilling localized with prolonged floor plasmons. J Phys Chem C. 2015;119(33):19382–9.
Abutoama M, Bajaj A, Li D, Wang YW, Jiang L, Abdulhalim I. Resonant modes of reflecting gratings engineered for multimodal sensing. APL Photon. 2020;5(7): 076108.
Shrivastav AM, Cvelbar U, Abdulhalim I. A complete evaluation on plasmonic-based biosensors utilized in viral diagnostics. Commun Biol. 2021;4(1):70.
Tabakman SM, Lau L, Robinson JT, Value J, Sherlock SP, Wang HL, et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic vary. Nat Commun. 2011;2:466.
Koh B, Li XY, Zhang B, Yuan B, Lin Y, Antaris AL, et al. Seen to near-infrared fluorescence enhanced mobile imaging on plasmonic gold chips. Small. 2016;12(4):457–65.
Li XY, Kuznetsova T, Cauwenberghs N, Wheeler M, Maecker H, Wu JC, et al. Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive coronary heart illness. Proc Natl Acad Sci U S A. 2017;114(27):7089–94.
Liu TC, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson CV, et al. Quantification of antibody avidities and correct detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020;4(12):1188–96.
Cao YL, Wang J, Jian FC, Xiao TH, Tune WL, Yisimayi A, et al. Omicron escapes the vast majority of present SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657–63.
Zou J, Xia HJ, Xie XP, Kurhade C, Machado RRG, Weaver SC, et al. Neutralization in opposition to omicron SARS-CoV-2 from earlier non-Omicron an infection. Nat Commun. 2022;13(1):852.
Wabl M, Cascalho M, Steinberg C. Hypermutation in antibody affinity maturation. Curr Opin Immunol. 1999;11(2):186–9.
Hurlburt NK, Seydoux E, Wan YH, Edara VV, Stuart AB, Feng JL, et al. Structural foundation for potent neutralization of SARS-CoV-2 and position of antibody affinity maturation. Nat Commun. 2020;11(1):5413.
Vollmers HP, Brändlein S. Pure IgM antibodies: from parias to parvenus. Histol Histopathol. 2006;21(12):1355–6.
Boes M. Position of pure and immune IgM antibodies in immune responses. Mol Immunol. 2000;37(18):1141–9.
Suryawanshi RK, Chen IP, Ma TC, Syed AM, Brazer N, Saldhi P, et al. Restricted cross-variant immunity from SARS-CoV-2 Omicron with out vaccination. Nature. 2022;607(7918):351–5.
Liu LH, Iketani S, Guo YC, Chan JFW, Wang M, Liu LY, et al. Hanging antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2022;602(7898):676–81.
Bekliz M, Adea Ok, Vetter P, Eberhardt CS, Hosszu-Fellous Ok, Vu DL, et al. Neutralization capability of antibodies elicited by homologous or heterologous an infection or vaccination in opposition to SARS-CoV-2 VOCs. Nat Commun. 2022;13(1):3840.
Aydar Y, Sukumar S, Szakal AK, Tew JG. The affect of immune complex-bearing follicular dendritic cells on the IgM response, Ig class switching, and manufacturing of excessive affinity IgG. J Immunol. 2005;174(9):5358–66.
Tseng CE, Donato FD, Buyon JP. Stability of immunoblot profile of anti-SSA/Ro-SSB/La antibodies over time in moms whose youngsters have neonatal lupus. Lupus. 1996;5(3):212–5.
Li QQ, Nie JH, Wu JJ, Zhang L, Ding RX, Wang HX, et al. SARS-CoV-2 501Y.V2 variants lack larger infectivity however do have immune escape. Cell. 2021;184(9):2362–71.
Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7(8):1161–79.
Tang JJ, Novak T, Hecker JL, Grubbs G, Zahra FT, Bellusci L, et al. Cross-reactive immunity in opposition to the SARS-CoV-2 Omicron variant is low in pediatric sufferers with prior COVID-19 or MIS-C. Nat Commun. 2022;13(1):2979.
Pérez-Then E, Lucas C, Monteiro VS, Miric M, Brache V, Cochon L, et al. Neutralizing antibodies in opposition to the SARS-CoV-2 delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat Med. 2022;28(3):481–5.
